(Q43791889)

26 November 2017

title

Bronchodilatory and anti-inflammatory properties of inhaled selective phosphodiesterase inhibitors in a guinea pig model of allergic asthma (English)

1 reference

26 November 2017

Santing RE

1

1 reference

26 November 2017

de Boer J

2

1 reference

26 November 2017

Rohof A

3

1 reference

26 November 2017

van der Zee NM

4

1 reference

26 November 2017

Zaagsma J

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

European Journal of Pharmacology

26 November 2017

published in

1 reference

26 November 2017

volume

429

1 reference

26 November 2017

issue

1-3

1 reference

26 November 2017

page(s)

335-344

1 reference

The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Inhibition of allergen-induced lung eosinophilia by type-III and combined type III- and IV-selective phosphodiesterase inhibitors in brown-Norway rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Modulation of TNF alpha and IL-1 beta from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

cAMP-specific phosphodiesterase inhibitor, rolipram, reduces eosinophil infiltration evoked by leukotrienes or by histamine in guinea pig conjunctiva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Inhibition of eotaxin-mediated human eosinophil activation and migration by the selective cyclic nucleotide phosphodiesterase type 4 inhibitor rolipram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

A novel method to assess airway function parameters in chronically instrumented, unrestrained guinea-pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Relationships among allergen-induced early and late phase airway obstructions, bronchial hyperreactivity, and inflammation in conscious, unrestrained guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

The importance of eosinophil activation for the development of allergen-induced bronchial hyperreactivity in conscious, unrestrained guinea-pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

PDE isoenzymes as targets for anti-asthma drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

The effect duration of selective phosphodiesterase inhibitors in the guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Analysis of the beta-adrenoceptor mediated inhibition of IgG1 and IgE dependent guinea-pig anaphylactic tracheal smooth muscle contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

A kinetic assay for eosinophil peroxidase activity in eosinophils and eosinophil conditioned media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901333-4

10.1016/S0014-2999(01)01333-4

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference